SCHEMBL29601197

SCHEMBL29601197

O=C(NCC(F)(F)F)c1ccnc(Nc2nc(-c3ccccn3)c(CCl)s2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 3/20 0.42
CDK7 P50613 3/20 0.42
GABRA5 P31644 3/20 0.42
ULK1 O75385 1/20 0.39
AR P10275 1/20 0.38
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
MAPK14 Q16539 1/20 0.36
KDR P35968 2/20 0.35
TGFBR1 P36897 1/20 0.34
KCNN1 Q92952 1/20 0.34
KCNN2 Q9H2S1 1/20 0.34
KCNN3 Q9UGI6 1/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 2/20 0.34
ADORA3 P0DMS8 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24358184 0.92 GABRA5 (0.42) CHEK1CDK7GABRA5ULK1AR
SCHEMBL30745668 0.92 GABRA5 (0.42) CHEK1CDK7GABRA5ULK1AR
SCHEMBL29601482 0.87 GABRA5 (0.45) CHEK1CDK7GABRA5ULK1CDK5
SCHEMBL24358064 0.87 GABRA5 (0.45) CHEK1CDK7GABRA5ULK1CDK5
SCHEMBL24358115 0.83 SCN9A (0.40) CHEK1CDK7GABRA5ULK1AR
SCHEMBL24358123 0.83 SCN9A (0.40) CHEK1CDK7GABRA5ULK1AR
SCHEMBL29601458 0.83 SCN9A (0.40) CHEK1CDK7GABRA5ULK1AR
SCHEMBL24358255 0.81 KCNN1 (0.56) KCNN1KCNN2KCNN3MEN1ALDH1A1
SCHEMBL29601694 0.81 KCNN1 (0.56) KCNN1KCNN2KCNN3MEN1ALDH1A1
SCHEMBL29078720 0.80 IDH2 (0.39) KCNN1KCNN2KCNN3MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed